TY - JOUR
T1 - Correlations between apolipoprotein E ε4 gene dose and whole brain atrophy rates
AU - Chen, Kewei
AU - Reiman, Eric M.
AU - Alexander, Gene E.
AU - Caselli, Richard J.
AU - Gerkin, Richard
AU - Bandy, Daniel
AU - Domb, Alisa
AU - Osborne, David
AU - Fox, Nick
AU - Crum, William R.
AU - Saunders, Ann M.
AU - Hardy, John
PY - 2007/6
Y1 - 2007/6
N2 - Objective: The purpose of this study was to characterize the relationship between whole brain atrophy rates and three levels of genetic risk for Alzheimer's disease in cognitively normal persons. The authors previously found accelerated whole brain atrophy rates in patients with probable Alzheimer's disease by computing changes in brain volume from sequential magnetic resonance images (MRIs). Methods: The authors assessed 36 late-middle-aged persons from three genetic groups: those with two, one, and no copies of the apolipoprotein E (APOE) ε4 allele, a common Alzheimer's disease susceptibility gene. The participants had clinical ratings, neuropsychological tests, and volumetric T1-weighted MRIs during a baseline visit and again approximately 2 years later. Two different image-analysis techniques, brain boundary shift integration and iterative principal component analysis, were used to compute whole brain atrophy rates. Results: While there were no baseline, follow-up, or between-visit differences in the clinical ratings or neuropsychological test scores among the three subject groups, whole brain atrophy rates were significantly greater in the ε4 homozygote group than in noncarriers and were significantly correlated with ε4 gene dose (i.e., the number of ε4 alleles in a person's APOE genotype). Conclusion: Since APOE ε4 gene dose is associated with an increased risk of Alzheimer's disease and a younger median age at dementia onset, this study suggests an association between the risk of Alzheimer's disease and accelerated brain atrophy rates before the onset of cognitive impairment.
AB - Objective: The purpose of this study was to characterize the relationship between whole brain atrophy rates and three levels of genetic risk for Alzheimer's disease in cognitively normal persons. The authors previously found accelerated whole brain atrophy rates in patients with probable Alzheimer's disease by computing changes in brain volume from sequential magnetic resonance images (MRIs). Methods: The authors assessed 36 late-middle-aged persons from three genetic groups: those with two, one, and no copies of the apolipoprotein E (APOE) ε4 allele, a common Alzheimer's disease susceptibility gene. The participants had clinical ratings, neuropsychological tests, and volumetric T1-weighted MRIs during a baseline visit and again approximately 2 years later. Two different image-analysis techniques, brain boundary shift integration and iterative principal component analysis, were used to compute whole brain atrophy rates. Results: While there were no baseline, follow-up, or between-visit differences in the clinical ratings or neuropsychological test scores among the three subject groups, whole brain atrophy rates were significantly greater in the ε4 homozygote group than in noncarriers and were significantly correlated with ε4 gene dose (i.e., the number of ε4 alleles in a person's APOE genotype). Conclusion: Since APOE ε4 gene dose is associated with an increased risk of Alzheimer's disease and a younger median age at dementia onset, this study suggests an association between the risk of Alzheimer's disease and accelerated brain atrophy rates before the onset of cognitive impairment.
UR - http://www.scopus.com/inward/record.url?scp=34250801552&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=34250801552&partnerID=8YFLogxK
U2 - 10.1176/ajp.2007.164.6.916
DO - 10.1176/ajp.2007.164.6.916
M3 - Article
C2 - 17541051
AN - SCOPUS:34250801552
SN - 0002-953X
VL - 164
SP - 916
EP - 921
JO - American Journal of Psychiatry
JF - American Journal of Psychiatry
IS - 6
ER -